India bans Remdesivir exports till COVID surge abates : Bulletin: Business Today
Business Today
Loading...
 

India bans Remdesivir exports till COVID surge abates

Loading the player...

Rashi Bisaria | April 12, 2021

India bans Remdesivir exports till COVID surge abates

India has banned the export of Remdesivir injection and active pharmaceutical ingredients (API) used for making the coronavirus medication till the recent surge in COVID-19 cases subsides. India has been witnessing a surge in COVID-19 cases with the second wave of the pandemic. As of Sunday, the number of active cases stood at 11.08 lakh. This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patients.

Abhijit Banerjee defends government intervention to uplift poor

Renowned economist and Nobel laureate Abhijit Vinayak Banerjee has trashed the ideology that calls for lesser or limited government interventions towards uplifting the poor arguing that such freebies make the poor lazy, saying there is no evidence whatsoever proving so. He said his own research proves that those who have benefited from public and non-governmental interventions wherein they were given free assets did in fact became more productive and creative. He was addressing the 20th foundation day of Bandhan Bank, the non-profit-turned-MFI-turned-small finance bank.

Amazon India launches 'Mentor Connect' for start-ups, emerging brands

Amazon India announced the launch of its 'Mentor Connect' programme on April 11. It is aimed at accelerating the growth of start-ups and emerging brand owners enrolled under its Amazon Launchpad initiative.Mentors from educational institutions and VC firms like Fireside Ventures, DSG Consumer Partners, Elevation Capital, Tomorrow Capital have already signed up for the programme to contribute to the Indian start-up growth story.

China mulls mixing COVID-19 vaccines to 'optimise' production

China's top disease control official has said the country is formally considering mixing COVID-19 vaccines, as a way of further boosting vaccine efficacy. Available data shows Chinese vaccines lag behind others including Pfizer and Moderna in terms of efficacy, but require less stringent temperature controls during storage.

Infosys to consider share buyback on April 14

Indian IT major Infosys will consider a share buyback plan in its board meeting scheduled on April 14. Infosys is expected to hold board meetings on April 13 and 14 to approve and take on record financial results for quarter and fiscal ended March 31, 2021.

COVID-19 vaccination to resume at 62 private centres in Mumbai today

With the fresh stock of anti- COVID 19 vaccines being made available by the Mumbai civic body, the halted vaccination drive will resume at 62 of the 71 designated private hospitals in the megapolis from April 12, municipal commissioner Iqbal Singh Chahal said on Sunday.The vaccination centres in the 71 private hospitals stopped functioning on April 10 and April 11 due to the shortage of vaccines.

More from this section